MAPK8 and benign prostatic hyperplasia: The phosphorylation of c-Jun N-terminal kinase (JNK) (indicating its activation) was elevated in the BPH group compared with the NC group but reduced in the finasteride and PV groups compared to the BPH group (Figure 7).